FDA.reportPublic FDA data

1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega]

RxCUI
1650974
RxNorm name
1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega]
Display name
1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega]
Full name
1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INVEGA TRINZAPALIPERIDONE PALMITATEJanssen Pharmaceuticals, Incc39e65d7-fa44-4e4c-8b12-a654d3ed0eae2025-02-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1650974

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c39e65d7-fa44-4e4c-8b12-a654d3ed0eae1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega]SBD25These highlights do not include all the information needed to use INVEGA TRINZA safely and effectively. See full prescribing information for INVEGA TRINZA. INVEGA TRINZA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620250214
c39e65d7-fa44-4e4c-8b12-a654d3ed0eaeInvega Trinza 546 MG in 1.75 ML Prefilled SyringePSN25These highlights do not include all the information needed to use INVEGA TRINZA safely and effectively. See full prescribing information for INVEGA TRINZA. INVEGA TRINZA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620250214
c39e65d7-fa44-4e4c-8b12-a654d3ed0eaeInvega 546 MG per 1.75 ML Prefilled SyringeSY25These highlights do not include all the information needed to use INVEGA TRINZA safely and effectively. See full prescribing information for INVEGA TRINZA. INVEGA TRINZA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620250214
c39e65d7-fa44-4e4c-8b12-a654d3ed0eae1.75 ML Invega 312 MG/ML Prefilled SyringeSY25These highlights do not include all the information needed to use INVEGA TRINZA safely and effectively. See full prescribing information for INVEGA TRINZA. INVEGA TRINZA ® (paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200620250214